Pages that link to "Q36057340"

The following pages link to The Role of receptor for Advanced Glycation End Products (RAGE) in the proliferation of hepatocellular carcinoma (Q36057340):

Displaying 26 items.

• The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review (Q26782281) (← links)
• Potential role of High mobility group box 1 in hepatocellular carcinoma (Q26864508) (← links)
• Role of receptor for advanced glycation end products (RAGE) in liver disease (Q27010462) (← links)
• Multiple criteria optimization joint analyses of microarray experiments in lung cancer: from existing microarray data to new knowledge. (Q31005911) (← links)
• The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation (Q33556403) (← links)
• HMGB1 in health and disease (Q34622835) (← links)
• RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma. (Q34716082) (← links)
• AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation (Q35835242) (← links)
• Specific siRNA targeting receptor for advanced glycation end products (RAGE) decreases proliferation in human breast cancer cell lines (Q36820542) (← links)
• Glycyrrhizin protects against porcine endotoxemia through modulation of systemic inflammatory response (Q36902374) (← links)
• Emerging role of high-mobility group box 1 (HMGB1) in liver diseases (Q37446034) (← links)
• The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines (Q37678815) (← links)
• Receptor for advanced glycation end products (RAGE) and its ligands: focus on spinal cord injury (Q38234624) (← links)
• Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling (Q38948698) (← links)
• Hypoxia driven glycation: Mechanisms and therapeutic opportunities. (Q39331191) (← links)
• The dual role and therapeutic potential of high-mobility group box 1 in cancer (Q42362799) (← links)
• The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC). (Q47095662) (← links)
• MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma. (Q52590673) (← links)
• Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy. (Q53708416) (← links)
• The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications. (Q55181875) (← links)
• Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma (Q58699656) (← links)
• High-Mobility Group Box-1 and Liver Disease (Q58760274) (← links)
• RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer-a Review (Q89484239) (← links)
• Local and Systemic Immune Dysregulation Alters Glioma Growth in Hyperglycemic Mice (Q89531610) (← links)
• The role of phosphatidylserine recognition receptors in multiple biological functions (Q90745873) (← links)
• The HMGB1-RAGE axis modulates the growth of autophagy-deficient hepatic tumors (Q94550192) (← links)